Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Trial Testing the Dose Escalation and Expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration for the Management of Pleural Carcinosis

NCT06281860 is registered in ClinicalTrials.gov with Dr Jean Yannis PERENTES as lead sponsor.

NCT NCT06281860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06281860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Trial Testing the Dose Escalation and Expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration for the Management of Pleural Carcinosis
Lead sponsor
Dr Jean Yannis PERENTES
Phase
Phase 1
Overall status
Unknown status
Start date
November 24, 2023
Completion date
February 1, 2026
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma breast stage iv, carcinoma, non-small-cell lung, esophageal cancer, gastric cancer, mesothelioma, malignant, ovarian cancer